By Sara Sjolin, MarketWatch
LONDON (MarketWatch) -- Here are some of the companies whose
shares made notable moves in European trade on Friday.
Gainers
Novo Nordisk(NVO) gained 2.7% after a U.S. Food and Drug
Administration advisory panel recommended approval of the Danish
drug maker's diabetes drug as a treatment for obesity. The
treatment, knows as Victoza, will be marketed as Saxenda if it is
approved as an obesity drug.
Shares of Pandora climbed 1.2% after the Danish jewelry company
said it had entered into a strategic alliance with Bluebell about
distribution in Japan.
Assa Abloy rose 1.6% after the Swedish lock maker said it is
buying Jiawei, a supplier of security locks in China.
Decliners
Aveva Group sank 25% after the software company issued a profit
warning, saying first-half will be hit by "material" currency
effects and the timing of some key rental renewals.
Shares of RWE lost 1.8% after news that the German utility
company is seeking further cost cuts at its conventional power
generation business. In addition, J.P. Morgan Cazenove cut RWE to
underweight from neutral.
Aviva fell 1% after Barclays appointed John McFarlane, chairman
of the U.K. insurer, as its next chairman.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires